DOI: http://dx.doi.org/10.18203/2349-2902.isj20221164

A rare case of malignant pancreatic non-functional neuroendocrine tumor presenting as huge abdominal lump

Pradeep Saxena, Swastik Bhardwaj, Tarun Sutrave, Ankit Lalchandani

Abstract


We present a case of an exceptionally large size non-functioning pancreatic neuroendocrine tumor (PNET) in a young female. The tumor occupied the whole abdomen and pelvis and was clinically masqueraded as an ovarian tumor. Imaging with contrast enhanced CT scan and magnetic resonance imaging of the abdomen aided in preoperative diagnosis of origin of the tumor from the pancreas. Distal pancreatectomy with splenectomy and left hemicolectomy was done. Primary colocolic anastomosis was done for reconstruction. Postop course was uneventful, and patient was discharged with advice to undergo adjuvant chemotherapy. Surgical excision of large size locally advanced non-functional PNET should be done with curative intention/ to treat symptoms and improve patient survival       


Keywords


Neuroendocrine tumor of pancreas, Non-functioning PNET, Malignancy of pancreas, Distal pancreatectomy

Full Text:

PDF

References


Roshan D, Shortridge K, Schuster R. A Case of a Large Non-Functional Pancreatic Neuroendocrine Tumor: A Case Report and a Review of the Literature. Ann Clin Case Rep. 2020;5:1861.

Kanthan R, Senger JL, Ahmed S, Kanthan SC. Pancreatic Neuroendocrine Tumors in the 21st Century-An Update. Clin Surg. 2017;2:1662.

Cynthia RO, Chai W, V, Yu VE, Run Yu. Pancreatic neuroendocrine tumors: biology, diagnosis and treatment. Chin J Cancer. 2013;32(6):312-4.

Kasajima A, Yazdani S, Sasano H. Pathology diagnosis of pancreatic neuroendocrine tumors. J Hepatobiliary Pancreat Sci. 2015;22:586-93.

Memeh KO, Vaghaiwalla T, Keutgen XM. Surgical treatment of non-functioning pancreatic neuroendocrine tumors: current controversies and challenges. J Pancreatol. 2020;3:51-8.

Tierney JF, Chivukula SV, Wang X. Resection of primary tumor may prolong survival in metastatic gastroenteropancreatic neuroendocrine tumors. Surgery. 2019;165:644-51.

Masui T, Anazawa T, Takaori K, Uemoto S. The Surgical Management of Non-Functioning Pancreatic Neuro-Endocrine Tumors. JOP. J Pancreas (Online). 2018;S(3):354-7.

Han SH, Han IW, Heo JS, Choi SH, Choi DW, Han S, et al. Laparoscopic versus open distal pancreatectomy for nonfunctioning pancreatic neuroendocrine tumors: a large single-center study. Surg Endosc. 2017;28664429.

Fischer L, Bergmann F, Schimmack S, Hinz U, Prieß S, Müller-Stich BP, et al. Outcome of surgery for pancreatic neuroendocrine neoplasms. Br J Surg. 2014;101:1405-12.

Sarmiento JM, Heywood G, Rubin J, Ilstrup DM, Nagorney DM, Que FG. Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg. 2003;197:29-37.

Elias D, Lasser P, Ducreux M, Duvillard P, Ouellet JF, Dromain C, et al. Liver resection (and associated extrahepatic resections) for metastatic well-differentiated endocrine tumors: a 15-year single center prospective study. Surgery. 2003;133:375-82.

Zhou B, Zhan C, Ding Y. Role of palliative resection of the primary pancreatic neuroendocrine tumor in patients with unresectable metastatic liver disease: a systematic review and meta-analysis. Onco Targets Ther. 2018;11:975-82.

Mayo SC, De Jong MC, Bloomston M, Pulitano C, Clary BM, Reddy SK, et al. Surgery versus intra-arterial therapy for neuroendocrine liver metastasis: a multicenter international analysis. Ann Surg Oncol. 2011;18:3657-65.

Yao JC, Shah MH, Ito T, Bohas CL, Wolin EM, Van Cutsem E, et al. Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med. 2011;364:514-23.

Raymond E, Dahan L, Raoul JL, Bang YJ, Borbath I, Lombard-Bohas C, et al. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N Engl J Med. 2011;364:501-13.